RELEASE OF THE AACR CANCER PROGRESS REPORT 2022: Decoding Cancer Complexity. Integrating Science. Transforming Patient Outcomes

National Press Club, 529 14th St. NW, 13th Floor, Washington, D.C. 20045

SEPTEMBER 21, 2022

read report view flyer

The American Association for Cancer Research (AACR) officially released the AACR Cancer Progress Report 2022: Decoding Cancer Complexity. Integrating Science. Transforming Patient Outcomes during a briefing on September 21. This 12^th edition of the AACR CPR follows President Biden’s decision to reignite the Cancer Moonshot 2.0, which leverages a whole-of-government approach to increase access to cancer screenings, address disparities, and improve the experience of people and their families living with cancer. 

The CPR is a cornerstone of the efforts of the AACR to educate policymakers and the broader public about cancer, highlight the remarkable progress we are making against cancer, and advocate for robust, sustained, and predictable annual funding increases for the NIH, NCI, FDA, and CDC.  Specifically, the report underscores how recent advances across the clinical cancer care continuum, in particular immunotherapy and molecularly-targeted therapies, are helping cancer patients and their loved ones. This year’s report also focuses on the ways we are addressing the needs of the rapidly expanding population of cancer survivors, as well as the disparities that unfortunately still continue to exist in certain populations. 

WELCOME

Margaret Foti, PhD, MD (hc)
Chief Executive Officer of the AACR
Philadelphia, Pennsylvania

REMARKS

The Honorable Nikema Williams
U.S. Representative for Georgia’s 5^th Congressional District

SPEAKERS

Lisa Coussens, PhD, FAACR
AACR President 2022-2023
Chair, Department of Cell, Developmental and Cancer Biology
Associate Director for Basic Research OHSU Knight Cancer Institute
Portland, Oregon

John Carpten, PhD, FAACR
Member, AACR Board of Directors
Chair, AACR Cancer Disparities Progress Report Steering Committee 2020
Chair of the Department of Translational Genomics and the Translational Genomics Institute
USC Norris Comprehensive Cancer Center-Keck School of Medicine
Los Angeles, California

Anna D. Barker, PhD, FAACR
Chief Strategy Officer, Ellison Institute for Transformative Medicine
Los Angeles, CA

Johnny Borgstrom, Stage IV Melanoma
Big Cabin, Oklahoma

Alexandra Vitale, Von Hippel-Lindau Syndrome
Townsend, Delaware